pharmaceutical investing La Jolla Pharmaceutical Company Gets European Commission Approval for GIAPREZA
pharmaceutical investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
pharmaceutical investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Yescarta (Axicabtagene Ciloleucel) Receives European Marketing Authorization for the Treatment of Relapsed or Refractory DLBCL and PMBCL
pharmaceutical investing Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA (lenvatinib) as First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma
Blue Jay Gold Announces Closing of Private Placement With Ocean Partners for Proceeds of $3.0 Million
Ucore Receives Louisiana Air Permit Covering Full 9,600 tpa Build-Out of Its Strategic Metals Complex
QIMC Sets Out Five-Phase Plan to Test Hydrogen Extraction at Bennett Hill, Nova Scotia, on the Path to Commercialization